CompletedNCT00208195
Divalproex extended release for mania with substance use in bipolarity
About this title
Read the official source — NCT00208195Medication studyAges 19–65United States
Understand this study
Who was this study for?
Listed age limits: 19 years to 65 years.
- Listed locations
- OmahaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMarch 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Creighton University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT00208195
- Official title
Show the full official title
Depakote ER Therapy for Mania Comorbid With Substance Abuse
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Omaha
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Creighton University, a university.
Did this study involve medication?
Yes. The study involved medication, including Divalproex ER.
Who was this study for?
Listed age limits: 19 years to 65 years.
